FDAFDA · Food and drugs·Recall number D-1206-2018
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.
Published September 19, 2018 · Recall initiated: August 21, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- HYDROCHLOROTHIAZIDE
- Manufacturer
- Accord Healthcare, Inc.
- Distributor
- Nationwide in the USA and Puerto Rico.
- Lot
- Lot: PW05264, Exp. 11/2019
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.